Enanta Pharmaceuticals
ENTA
$13.34
Share price
0.76%
Change (1 day)
-48.43%
Change (1 year)
Categories
Market capitalization of Enanta Pharmaceuticals (ENTA)
Market cap: $0.28 Billion
As of May 2024 Enanta Pharmaceuticals has a market cap of $0.28 Billion. This makes Enanta Pharmaceuticals the world's 6655th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Enanta Pharmaceuticals from 2013 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.28 B | 42.58% |
| 2023 | $0.19 B | -79.52% |
| 2022 | $0.96 B | -36.9% |
| 2021 | $1.53 B | 81.39% |
| 2020 | $0.84 B | -30.93% |
| 2019 | $1.22 B | -11.09% |
| 2018 | $1.37 B | 22.66% |
| 2017 | $1.12 B | 75.95% |
| 2016 | $0.63 B | 2.78% |
| 2015 | $0.62 B | -34.43% |
| 2014 | $0.94 B | 93.12% |
| 2013 | $0.49 B |
End of Day market cap according to different sources
On May 15th, 2024 the market cap of Enanta Pharmaceuticals was reported to be:
$0.28 Billion
$0.28 Billion
$0.28 Billion
$0.28 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $367.42 B | 129,947.68% | 🇺🇸 USA |
 Novartis NVS | $210.61 B | 74,443.85% | 🇨🇭 Switzerland |
 AbbVie ABBV | $289.23 B | 102,270.92% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $112.89 B | 39,858.35% | 🇺🇸 USA |
 Merck MRK | $333.64 B | 117,991.28% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $90.30 B | 31,863.43% | 🇺🇸 USA |